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INTRODUCTION  
The intramedullary spinal tumors (IMSTs) mainly occur
in the cervicothoracic or thoracic region and rarely in conus
medullaris, occupying approximately 10% of IMSTs16,17).
Specific intramedullary lesions of conus medullaris,
including tumor and infection, have been reported in case
reports2,3,6-8,18). Even though conus medullaris tumors have
different characteristics compared to IMSTs located at
other site, but there has been no analysis on primary tumors
in conus medullaris. 
The objective of this study was to analyze the characteristics
of clinical manifestation, radiological findings, treatment
methods, histopathologic types and outcomes of conus
medullaris tumor.
MATERIALS AND METHODS 
We retrospectively reviewed 26 consecutive patients who
underwent surgery for conus medullaris tumor at our
hospital from August 1986 to July 2007. Conus medullaris
tumor was defined as the primary tumor which occurred
purely at conus medullaris. We excluded tumors originated
from nerve root or meninges such as schwannoma and
meningioma and lipomas associated with spinal dysra-
phism. Medical informations analyzed for each patient
included clinical manifestation, preoperative MRI findings,
extent of surgical resection, histopathologic type, adjuvant
therapy, and outcomes including tumor recurrence. The
average of follow-up period was 50.2 (4-165) months. Final
follow-up was done by the interview at final outpatient visit
and by telephone. To evaluate of neurological outcome, we
checked the modified JOA score pre- and post-operatively
(Table 1). The modified JOA score was defined by exclu-
ding the category of upper motor and sensory function in
preexisting JOA score and focused on the bladder function
related with the conus medullaris tumor5). The visual
analogue scale (VAS) was used for low back pain and leg pain.
Objective : The objective of this study was to evaluate the characteristics and surgical outcome of the conus medullaris tumors.
Methods : We retrospectively reviewed 26 patients who underwent surgery for conus medullaris tumor from August 1986 to July 2007. We
analyzed clinical manifestation, preoperative MRI findings, extent of surgical resection, histopathologic type, adjuvant therapy, and outcomes.
Results : There were ependymoma (13), hemangioblastoma (3), lipoma (3), astrocytoma (3), primitive neuroectodermal tumor (PNET) (2), mature
teratoma (1), and capillary hemangioma (1) on histopathologic type. Leg pain was the most common symptom and was seen in 80.8% of patients.
Pain or sensory change in the saddle area was seen in 50% of patients and 2 patients had severe pain in the perineum and genitalia. Gross total or
complete tumor resection was obtained in 80.8% of patients. On surgical outcome, modified JOA score worsened in 26.9% of patients, improved
in 34.6%, and remained stable in 38.5%. The mean VAS score was improved from 5.4 to 1.8 among 21 patients who had lower back pain and leg
pain.
Conclusion : The surgical outcome of conus medullaris tumor mainly depends on preoperative neurological condition and pathological type. The
surgical treatment of conus medullaris tumor needs understanding the anatomical and functional characteristics of conus meudllaris tumor for better
outcome. 
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The gross total resection was defined as the removal of at
least 95% of the tumor on the microscopic view at the end
of the surgery and the postoperative MRI. The subtotal
resection was defined when 80-95% of the tumor was
resected13,16,17,20).
RESULTS   
Clinical presentation
Twenty-six patients underwent resection of conus medu-
llaris tumors (Table 2). The mean age of the patients was
39.5 years (13-65 years). Fifteen patients (61%) were men.
The mean symptom duration was 6.7 months (1-20 months)
and abrupt onset of symptom was seen in 2 patients
without prodromal symptoms. Leg pain was the most
common symptom and was seen in 80.8% of patients
(n=21), lower back pain in 69.2% (n=18), sensory change
in 69.2% (n=18), bladder and bowel dysfunction in 57.7%
(n=15), and motor weakness in 46.2% (n=12). Pain or
sensory change in saddle area was seen in 50.0% of patients
(n=13). Two patients had severe pain in the perineum and a
woman with severe genitalia pain underwent hysterectomy
6 months prior to the conus medullaris tumor resection
because she was diagnosed with non-symptomatic uterine
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Table 2. Demographics of 26 conus medullaris tumors
Symtom 
Follow-up
Preoperative symptom and sign
Specific
Case Age, sex Level duration
(months)
LBP/LP Motor Sensory B&B
MRI finding
(weeks) weakness change dysfunction
1 28, M L1-2 1 6 +/+ - - - Tumor bleeding
2 37, F T12-L2 56 108 -/- + + + -
3 46, M T11-12 4 35 +/+ - - - Cystic mass, Syringomyelia
4 44, M T12-L3 50 58 +/+ - + +
5 13, M T11-L3 4 56 -/- + + - Tumor bleeding, CSF seeding
6 32, F T11-L3 48 128 -/- + + +
7 36, M L1 90 26 +/+ - + + -
8 65, M L1-2 16 105 +/+ - + - -
9 30, M L1-2 18 25 +/+ - + + -
10 37, F L1-3 8 18 +/+ - - - -
11 17, M T12-L2 4 54 +/+ - - + -
12 48, F L1-T12 1 140 -/- + + +
13 34, F L1 96 139 -/- + + -
14 46, F L1-2 3 13 +/+ - + + -
15 40, M T9-L2 35 19 -/+ + + + -
16 48, F L2-3 55 4 -/+ - - - -
17 51, M T11-L1 12 15 +/+ + - + -
18 39, F L1-2 12 9 +/+ - + + -
19 41, M T11-L1 24 12 +/+ + + -
20 57, M L1-2 9 81 -/+ - - - -
21 61, M T12-L1 1 23 +/+ + + - Syringomyelia
22 37, F T12-L1 38 13 +/+ - + + Cystic mass
23 17, M T11-L2 2 24 +/+ + + + -
24 40, F T11-L1 38 8 +/+ + + + -
25 35, F T12-L2 22 21 +/+ + + + Cystic mass
26 49, M T11-L1 47 165 +/+ - - -
LBP/LP : Low back pain/Leg pain, B & B : bladder and bowl, GTR : gross total resection, STR : subtotal resection, ME : myxopapillary ependymoma
Table 1. Summary of modified JOA (Japanese Orthopaedic Association)
score
Modified JOA score
I. Motor function of the lower extremity
0. Impossible to walk
1. Needs cane or aid on flat ground
2. Needs cane or aid only on stairs
3. Possible to walk without cane or aid but slow
4. Normal
II. Sensory function of the lower extremity
0. Apparent sensory loss
1. Minimal sensory loss
2. Normal
III. Bladder function
0. Complete retention
1. Severe disturbance (sense of retention, dribbling, 
incomplete continence)
2. Mild disturbance (urinary frequency, urinary hesitancy)
3. Normal
myoma on the gynecologic evaluation and was unaware
that the genital pain comes from conus medullaris tumor
not from uterine myoma (Fig. 1).
Preoperative MRI findings
Regarding the tumor extension on preoperative MRI, the
involved masses less than 3 segments were 76.9% (n=20)
and those more than 3 segments beyond conus medullaris
were 23.1% (n=6). The mean involved segments were 2.8
segments. Three patients (11.5%) had cystic tumor mass, 2
patients (7.7%) had combined syringomyelia. Tumor
bleeding was seen in 2 patients (7.7%).
Surgical Result
Twenty-four patients underwent laminectomy and 2
younger patients with tumors involving long segments
underwent laminoplasty for prevention of postlaminectomy
kyphosis. Gross total or complete tumor resection was
performed in 80.8% of patients (n=21) and subtotal
resection was performed in 19.2% (n=5) because of unclear
demarcation between the tumor and normal neural tissue.
Pathology
The myxopapillary ependymoma, 13 cases (50.0%), was
most common in conus medullaris tumors. Other
histopathologic types were hemangioblastoma, 3 cases
(11.5%); lipoma, 3 cases (11.5%); astrocytoma, 3 cases
(11.5%); primitive neuroectodermal tumor (PNET), 2
cases (7.7%); capillary hemanigoma, 1 case (3.8%), and
mature teratoma, 1 case (3.8%).
Adjuvant therapy
Postoperative radiotherapy was done in 6 patients (ependy-
moma, 2; PNET, 2; astrocytoma, 1; hemangioblastoma, 1).
Postoperative chemotherapy was done in 2 patients with
PNET, which is highly malignant.
Surgical outcomes
The surgical outcomes were summarized in Table 3.
There was 1 case of CSF leakage as a postoperative complica-
tion, which was controlled with dura repair and compression
dressing. Tumor recurrence, including leptomeningeal
seeding, occurred in 26.9% of patients (n=7)(myxopapillary
ependymoma, 3; PNET, 2; astrocytoma, 3). Two patients
with recurred myxopapillary ependymoma and a patient
with pilocytic astrocytoma underwent radiotherapy and
one patient with myxopapillary ependyomoma underwent
radiotherapy and chemotherapy. One patient with recurred
astrocytoma underwent reoperation. Two patients with
astrocytoma and 1 patient with PNET died of tumor prog-
ression at 12, 15, and 24 months after surgery. Another
PNET tumor has been progressing in spite of postoperative
radiotherapy and chemotherapy.
On the neurological outcome, modified JOA score wors-
ened in 26.9% of patients (n=7), improved in 34.6%
(n=9), and remained stable in 38.5% (n=18) compared to
preoperative modified JOA score. Bladder and bowel
function improved completely in 15.4% of patients (n=4),
worsened in 15.4% (n=4), remained unchanged or
minimally improved in 85.7% (n=18). The mean visual
analogue scale (VAS) was improved from 5.4 to 1.8 among
21 patients who had low back pain and leg pain.
DISCUSSION
Conus medullaris tumor occupy approximately 10% of
IMSTs and most of tumor are ependymoma, especially
myxopapillary type18,19). Generally, IMSTs lead to myelop-
athy such as sensory change or motor weakness16,19).
However, in our study, the presenting symptoms of conus
medullaris tumor were different from
IMSTs at other site. The most com-
mon symptoms were sciatica (90.5%)
and low back pain (76.2%). In addi-
tion, bladder and bowel dysfunction
(61.9%) were also common. Uchiy-
ama et al. reported that 58% of
patients with epiconus/conus medull-
aris tumors had voiding symptoms
and especially, decreased urge to void,
detrusor-sphinter dyssynergia and
detrusor areflexia on voiding were the
main symptom on urodynamic
study21). Urinary symptoms may be
the sole initial symptoms, but urinary
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Fig. 1. Pre- and Post-operative magnetic resonance image of lipoma at the conus medullaris
(case 16). A : The lipoma at the conus medullaris was revealed with high signal density on T1
weighted MRI. B : The lipoma suppressed typically on the Fat suppression MRI. C : The tumor was
removed gross totally on the post operative MRI.
A B C
dysfunction tends to appear later. There may be no
significant relationship between lower motor neuron signs
and urinary symptoms. Two patients had severe perineal pain,
and genitalia pain seemed to originate from sacral nerve
root compression. These symptoms were misunderstood as
a gynecological problem, and the patient underwent
hysterectomy for the concordant uterine myoma before
conus medullaris tumor detection. These symptomatic
characteristics are due to the anatomical and functional
characteristics of the conus medullaris as sacral segments
and compression of lumbar nerve roots passing the conus
medullaris, and should be considered for differential
diagnosis of cauda equina syndrome or sciatica due to
degenerative lumbar diseases.
In our series, laminectomy was performed in 21 patients
and osteoplastic laminoplasty in 2 patients. There was no
deformity requiring surgical correction in the patients who
underwent only laminectomy at the final follow-up.
Sandalcioglu et al. demonstrated osteoplastic laminoplasty
did not reduce the risk of spinal deformities compared to
patients who underwent laminectomy, and their current
surgical strategy consisted of reconstruction of the posterior
spinal column and refixation of the laminotomy block with
microplates16).
Recently, advanced microsurgical techniques and intraope-
rative neurophysiological monitorings have made more
aggressive approach for total or near-total resection of intra-
medullary tumor10,15). In most reports, total or gross total
resection of IMSTs has been reported as 65-90%11,18-20).
However, there are the limitations of total resection due to
unclear demarcation between the tumor and normal neural
tissue and the resulting risk of injury to neural tissue. We
achieved 80.8% of gross total resection and there may be
no meaningful difference compared with IMSTs at other
site. Several authors reported this variation of the resec-
tability depends on the surgical technique and the surgeon’s
attitude1,16). Others reported a difference of tumor resectability
according to the histopathological type of tumors4,5,16,20).
Generally, the rate of complete removal is approximately
90% for ependymoma and hemangioblastoma and 50%-
76% in low grade astrocytoma. In our cases, total resection
of ependymoma was achieved in 89%, which is similar to
Surgical Treatment of Primary Spinal Tumors in the Conus Medullaris ｜IH Han, et al.
75
Table 3. Outcome of 26 conus medullaris tumors
Case Surgery Histology
Adjuvant 
Recurrence
Additional therapy Preop JOA score Postop JOA score Final
therapy after recurrence (bladder function) (bladder function) outcome
1 GTR ME - - - 9 (3) 9 (3)
2 GTR ME - - - 5 (2) 5 (2)
3 GTR ME RT - - 9 (3) 9 (3)
4 GTR ME - - - 6 (2) 9 (3)
5 GTR ME - + RT, CT 5 (2) 2 (0)
6 GTR ME - - - 6 (2) 5 (1)
7 GTR ME - - - 7 (2) 8 (2) 
8 GTR ME - - - 8 (3) 9 (3)
9 GTR ME RT - - 7 (2) 7 (2)
10 STR ME - + RT 9 (3) 9 (3)
11 GTR ME - + RT 7 (2) 7 (2)
12 GTR ME - - - 4 (2) 3 (2) 
13 GTR ME - - - 7 (2) 4 (0)
14 GTR Lipoma - - - 8 (2) 9 (3)
15 STR Lipoma - - - 6 (2) 6 (2)
16 GTR Lipoma - - - 8 (3) 7 (2)
17 GTR Astrocytoma - + RT 1 (0) 0 (0) Death
18 GTR Astrocytoma - - - 8 (2) 9 (3)
19 STR Astrocytoma RT + - 6 (2) 0 (0) Death
20 GTR Hemangioblastoma - - - 9 (3) 9 (3)
21 STR Hemangioblastoma RT - RT 7 (3) 7 (3)
22 GTR Hemangioblastoma - - - 7 (2) 9 (3)
23 STR PNET RT, CT + 2 (0) 3 (0) Death
24 GTR PNET RT, CT + - 0 (0) 0 (0) Progress
25 GTR Mature teratoma - - - 6 (2) 7 (2)
26 GTR Capillary hemangioma - - - 7 (2) 8 (2) 
JOA : Japanease Orthopaedic Association, ME : myxopapillary ependymoma, PA : pilocytic astrocyoma, RT : radiotherapy, CT : chemotherapy
reported rates. Tumor resectability of other histopatho-
logical types varied due to intraoperative decisions to avoid
injuring the normal neural tissue because the demarcation
between the tumor and normal neural tissue was not clear.
From our surgical experience of 26 patients, we noted that
the important point in the surgical resection of conus
tumor is the early detection and resection of filum terminale
attached with the tumor. Sometimes, the discrimination
between the conus medullaris and nerve roots is difficult to
determine because the nerve roots around the conus meullaris
are relatively thick compared to the distal portion of
lumbosacral nerve roots. In the pathological type of spinal
cord tumors, ependymoma was the most common,
comprising of 33-83% of IMSTs5,16,17). Myxopapillary
subtype was common. Other common pathological types
were lipoma, astrocytoma, and hemangioblastoma. In our
cases, myxopapillary ependymoma was found in 50% of
the total 26 cases and astrocytoma, lipoma, and hamangiob-
lastoma were the second common, found in 14.3% cases.
Rare tumor as PNET and mature teratoma occupied
individually 7.7% and 3.8%. In particular, PNET is highly
malignant as the average survival time is 20 months8).
Intramedullary mature teratoma of the conus medullaris is
also rare and 30 cases have been reported in our review of
the literature7).
On functional outcome, modified JOA score worsened in
7 patients (26.9%), improved in 9 patients (34.6%), and
remained stable in 10 patients (38.5%). The patient with
worsened modified JOA score was aggravated mainly in
urinary function, not motor function. The cause of aggra-
vation was due to aggressive total resection in spite of large
tumor size and unclear demarcation between tumor and
normal neural tissue. Though complete resection brings
relatively good tumor control, total resection should be
carefully considered. Five patients who had lower modified
JOA score below 5 points postoperatively also have poor
preoperative neurological condition. Therefore, the func-
tional outcome depended on the preoperative neurological
condition as in other reports of IMSTs14,18). The postoperative
bladder function may be the main factor on postoperative
neurological function and play an important role in patient’s
satisfaction in conus meudllaris tumor. In 3 patients with
cystic component, gross total resection could be easily per-
formed. All of the tumors were benign and the postoper-
ative neurological function was improved in three patients.
The cystic tumor lesion may be one predictor of good func-
tional outcome.
Postoperative adjuvant radiotherapy is still controversial,
especially for patients with low-grade tumor such as myxo-
papillary ependymoma and pilocytic astrocytoma. In our
series, postoperative adjuvant radiotherapy was not routinely
used in low-grade tumor and only used in the residual and
highly malignant tumor. Lee et al.11) reported that postop-
erative radiotherapy should only be considered as surgical
adjunct where gross total resection is not achieved and Lin
et al.12) reported postoperative local radiotherapy is recom-
mend and can achieve excellent local control and survival
for incomplete resection of ependymoma. We achieved
good local control in ependymoma as well as in 3 ependy-
momas with recurrence and leptomeningeal seeding after
gross-total resection. Koh et al. reported that fractional
external beam radiotherapy has a role in the management
of residual hemangioblastoma, especially for von Hippel-
Lindau disease9). We also used radiotherapy in one patient
with residual hemangioblastoma and achieved good local
control during follow-up period (23 months). Three patients
with PNET and astrocytoma died of the systemic tumor
progression at 12, 15, and 24 months after surgery. In 1
patient with PNET, tumor progressed in spite of the total
tumor resection, postoperative adjuvant radiotherapy, and
chemotherapy. The optimal treatment of PNET is unknown
because of the rarity of the tumor. Literature review has
shown that almost all spinal PNET cases were treated with
surgery and high dose radiotherapy of the tumor region
and entire neuraxis, and sometimes additional chemo-
therapy8). It revealed the tendency of longer survival in
patient treated with additional chemotherapy than patients
treated only surgical resection and radiotherapy8). Even
though PNET is highly malignant, aggressive adjuvant
therapy including chemotherapy may be considered.
CONCLUSION
The surgical outcome of conus medullaris tumor mainly
depends on preoperative neurological condition and histopa-
thological type. The surgical treatment of conus medullaris
tumor needs understanding the anatomical and functional
characteristics of conus medullaris tumor for better outcome.
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